Isbir Sentetik Dokuma Sanayi A.S. (IST:ISSEN)
9.01
+0.26 (2.97%)
At close: Sep 4, 2025
IST:ISSEN Income Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2020 |
4,522 | 3,866 | 4,189 | 3,814 | 1,117 | 596.09 | Upgrade | |
Revenue Growth (YoY) | 12.11% | -7.72% | 9.85% | 241.29% | 87.46% | 19.41% | Upgrade |
Cost of Revenue | 3,654 | 3,012 | 3,100 | 2,986 | 820.92 | 401.14 | Upgrade |
Gross Profit | 868.45 | 853.63 | 1,089 | 827.78 | 296.49 | 194.95 | Upgrade |
Selling, General & Admin | 325.24 | 312.03 | 314.3 | 198.99 | 70.22 | 40.92 | Upgrade |
Research & Development | - | - | - | 0.87 | 1.84 | 1.76 | Upgrade |
Other Operating Expenses | -265.64 | -8.39 | 1.28 | 76.01 | 3.93 | -6.14 | Upgrade |
Operating Expenses | 59.6 | 303.64 | 315.58 | 275.87 | 76 | 36.54 | Upgrade |
Operating Income | 808.84 | 549.99 | 773.87 | 551.91 | 220.49 | 158.4 | Upgrade |
Interest Expense | -731.54 | -226.04 | -147.38 | -235.32 | -32.08 | -21.02 | Upgrade |
Interest & Investment Income | 49.53 | 97.86 | 167.95 | 76.1 | 13.61 | 7.28 | Upgrade |
Earnings From Equity Investments | - | - | - | - | - | -4.93 | Upgrade |
Currency Exchange Gain (Loss) | -342.07 | -12.16 | -84.35 | -494.6 | -29.8 | -41.77 | Upgrade |
Other Non Operating Income (Expenses) | -399.02 | -516.35 | -622.27 | 158.33 | - | 3.1 | Upgrade |
EBT Excluding Unusual Items | -614.26 | -106.7 | 87.83 | 56.43 | 172.22 | 101.07 | Upgrade |
Gain (Loss) on Sale of Investments | 4.59 | -0.62 | 0.01 | 0.02 | - | - | Upgrade |
Legal Settlements | -10.32 | -10.6 | -10.04 | -5.61 | -4.75 | - | Upgrade |
Pretax Income | -619.99 | -117.92 | 77.8 | 50.84 | 167.47 | 101.07 | Upgrade |
Income Tax Expense | 275.37 | 71.85 | -284.18 | 181.05 | 33.84 | 21.23 | Upgrade |
Earnings From Continuing Operations | -895.36 | -189.77 | 361.98 | -130.22 | 133.63 | 79.84 | Upgrade |
Minority Interest in Earnings | 189.77 | 189.38 | -361.58 | 0.17 | 0.05 | - | Upgrade |
Net Income | -705.59 | -0.39 | 0.41 | -130.05 | 133.68 | 79.84 | Upgrade |
Net Income to Common | -705.59 | -0.39 | 0.41 | -130.05 | 133.68 | 79.84 | Upgrade |
Net Income Growth | - | - | - | - | 67.42% | 121.76% | Upgrade |
Shares Outstanding (Basic) | - | 424 | 378 | 378 | 384 | 378 | Upgrade |
Shares Outstanding (Diluted) | - | 424 | 378 | 378 | 384 | 378 | Upgrade |
Shares Change (YoY) | - | 12.28% | - | -1.44% | 1.48% | - | Upgrade |
EPS (Basic) | - | -0.00 | 0.00 | -0.34 | 0.35 | 0.21 | Upgrade |
EPS (Diluted) | - | -0.00 | 0.00 | -0.34 | 0.35 | 0.21 | Upgrade |
EPS Growth | - | - | - | - | 64.98% | 121.76% | Upgrade |
Free Cash Flow | -377.1 | -421.68 | -241.83 | -282.74 | 84.88 | -3.93 | Upgrade |
Free Cash Flow Per Share | - | -0.99 | -0.64 | -0.75 | 0.22 | -0.01 | Upgrade |
Dividend Per Share | 0.090 | 0.090 | 0.060 | 0.060 | - | - | Upgrade |
Dividend Growth | 50.00% | 50.00% | - | - | - | - | Upgrade |
Gross Margin | 19.20% | 22.08% | 26.00% | 21.71% | 26.53% | 32.70% | Upgrade |
Operating Margin | 17.89% | 14.23% | 18.47% | 14.47% | 19.73% | 26.57% | Upgrade |
Profit Margin | -15.60% | -0.01% | 0.01% | -3.41% | 11.96% | 13.40% | Upgrade |
Free Cash Flow Margin | -8.34% | -10.91% | -5.77% | -7.41% | 7.60% | -0.66% | Upgrade |
EBITDA | 961.72 | 593.69 | 887.07 | 630.11 | 230.51 | 165.79 | Upgrade |
EBITDA Margin | 21.27% | 15.36% | 21.17% | 16.52% | 20.63% | 27.81% | Upgrade |
D&A For EBITDA | 152.87 | 43.7 | 113.2 | 78.2 | 10.02 | 7.39 | Upgrade |
EBIT | 808.84 | 549.99 | 773.87 | 551.91 | 220.49 | 158.4 | Upgrade |
EBIT Margin | 17.89% | 14.23% | 18.47% | 14.47% | 19.73% | 26.57% | Upgrade |
Effective Tax Rate | - | - | - | 356.15% | 20.21% | 21.00% | Upgrade |
Advertising Expenses | - | 1.23 | 0.45 | 0.52 | 1.19 | 0.19 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.